The Dwarf-Star NIR Red-Wave spectrometer is designed with no moving parts to make it ideal for the field since it enables on-site product analysis and quality control, Laboratorytalk.com
NextPharma has over through 200 clients across the biotech, pharma and healthcare sectors. NextPharma provides manufacturing, product development, clinical trials and logistics services through its seven manufacturing facilities,
Provenge is a patient specific therapeutic cancer vaccine for prostate cancer (CaP). Dendreon, which expects to receive a European approval for the product’s marketing authorisation application (MAA) by
Vinton Healthcare owned a manufacturing unit and also partly owned Wockhardt‘s nutrition business along with two other subsidiaries – Wockhardt EU Operations (Swiss) and Carol Info Service, which
Most recently, Lundstrom worked as the head of Biogen Idec International Commercial Operations, and was responsible for sales and marketing in 28 countries and through distributors in over
Biogen Idec aims to cash in on the major role that biosimilars will play in health care in the near future. According to a US Congressional Budget Office
The milestone was reached on the transition of an oncology programme into lead optimisation. The collaboration was made for jointly indentifying and developing preclinical development candidates for the
MEDI-565 (MT111) is a BiTE antibody designed to direct a patient’s T cells, the body’s most potent killer cells, against cancer cells that express carcinoembryonic antigen (CEA). The
The collaboration will enable more patients to participate in trials of potential new cancer treatments that combine molecularly targeted experimental drugs developed and owned by AstraZeneca. The trials
GSK and ChemoCentryx said that the study will assess the efficacy and safety of ‘786 for inducing a response and remission (reduction or disappearance of symptoms) and maintaining
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.